Perseus Proteomics Inc. (4882.T)
JPY 610.0
(-0.65%)
JPY 610.0
(-0.65%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -833.89 Million | -564.27 Million | -476.84 Million | -422.83 Million | -608.52 Million |
| Net Income | -1.1 Billion | -785.07 Million | -597.09 Million | -411.28 Million | -841 Million |
| Depreciation & Amortization | 3.49 Million | 5.71 Million | 2.95 Million | 55 Thousand | 166 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 41.21 Million | 31.41 Million | - | - | - |
| Change in working capital | 108.6 Million | 95.61 Million | -14.5 Million | -10.75 Million | 226.29 Million |
| Other non-cash items | -36.69 Million | -5.54 Million | 15.86 Million | -177 Thousand | 841 Million |
| Investing Cash Flow | -150.34 Million | -212.98 Million | -33.86 Million | -2.82 Million | -3.4 Million |
| Investments in PPE | -158.97 Million | -170.54 Million | -33.86 Million | -2.82 Million | -2.6 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 8.62 Million | -42.44 Million | - | - | -803 Thousand |
| Financing Cash Flow | 63.94 Million | -20 Thousand | 2.64 Billion | 1.01 Billion | - |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -97 Thousand | -20 Thousand | - | - | - |
| Common Stock Issuance | 63.47 Million | - | 2.65 Billion | 1 Billion | - |
| Other Financing Activities | 565 Thousand | - | -4.86 Million | 3.04 Million | - |
| Accounts receivables | -3 Million | 301 Thousand | -1 Million | 1 Million | 187.24 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -1.22 Million | 109 Thousand | -1.37 Million | 565 Thousand | -59 Thousand |
| Other working capital | 117 Million | 99 Million | -6 Million | 10 Million | 39.11 Million |
| Cash at beginning of period | 2.44 Billion | 3.21 Billion | 1.06 Billion | 482.46 Million | 1.1 Billion |
| Cash at end of period | 1.54 Billion | 2.44 Billion | 3.21 Billion | 1.06 Billion | 482.46 Million |
| Capital Expenditure | -158.97 Million | -170.54 Million | -33.86 Million | -2.82 Million | -2.6 Million |
| Effect of forex changes on cash | 16.78 Million | 7.36 Million | 8.71 Million | 1.45 Million | - |
| Net cash flow / Change in cash | -903.51 Million | -769.91 Million | 2.14 Billion | 586.83 Million | -617.66 Million |
| Free Cash Flow | -992.86 Million | -734.82 Million | -510.71 Million | -425.66 Million | -611.13 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -219 Million | -205 Million | -1.1 Billion | -266 Million | -211 Million | -422 Million |
| Depreciation & Amortization | - | - | 3.49 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 41.21 Million | - | - | - |
| Change in working capital | - | - | 108.6 Million | - | - | - |
| Other non-cash items | 219 Million | 205 Million | -36.69 Million | 266 Million | 211 Million | 422 Million |
| Investing Cash Flow | - | - | -150.34 Million | - | - | - |
| Investments in PPE | - | - | -158.97 Million | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 8.62 Million | - | - | - |
| Financing Cash Flow | - | - | 63.94 Million | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -97 Thousand | - | - | - |
| Common Stock Issuance | - | - | 63.47 Million | - | - | - |
| Other Financing Activities | - | - | 565 Thousand | - | - | - |
| Accounts receivables | - | - | -3 Million | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -1.22 Million | - | - | - |
| Other working capital | - | - | 117 Million | - | - | - |
| Cash at beginning of period | - | - | 2.44 Billion | - | - | - |
| Cash at end of period | - | - | 1.54 Billion | - | - | - |
| Capital Expenditure | - | - | -158.97 Million | - | - | - |
| Effect of forex changes on cash | - | - | 16.78 Million | - | - | - |
| Net cash flow / Change in cash | - | - | -903.51 Million | - | - | - |
| Free Cash Flow | - | - | -992.86 Million | - | - | - |
6583
JGCCY
0LD9
MACIW
SKTP
LRS